GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 8,860.00
-240.00 (-2.64%)
At close: Feb 6, 2026
GC Genome Market Cap
GC Genome has a market cap or net worth of 209.55 billion as of February 6, 2026.
Market Cap
209.55B
Enterprise Value
172.28B
Revenue
30.79B
Ranking
n/a
PE Ratio
75.01
Stock Price
8,860.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 209.55B, a decrease of -20.18%. That is a compound annual growth rate of -29.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 209.55B | 29.91% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.14T |
| ALTEOGEN | 19.31T |
| Sam Chun Dang Pharm. | 11.63T |
| HLB Pharmaceutical | 218.78B |
| AptaBio Therapeutics | 216.32B |
| Vieworks | 216.25B |
| REYON Pharmaceutical | 212.57B |